The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

• Caroline J. Voskens,

  Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany

  ⨯
• Simone M. Goldinger,

  Affiliation Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Carmen Loquai ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany

  ⨯
• Caroline Robert,

  Affiliation Institute Gustave Roussy, Department of Dermatology, Villejuif, France

  ⨯
• Katharina C. Kaehler ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Kiel, Kiel, Germany

  ⨯
• Carola Berking,

  Affiliation Department of Dermatology and Allergology, University of Munich LMU, Munich, Germany

  ⨯
• Tanja Bergmann,

  Affiliation Department of Internal Medicine (Gastroenterology, Endocrinology, and Pneumology), University Hospital Erlangen, Erlangen, Germany

  ⨯
• Clemens L. Bockmeyer,

  Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany

  ⨯
• Thomas Eigentler ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Michael Fluck ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, Hospital Hornheide, Münster, Germany

  ⨯
• Claus Garbe,

  Affiliation Department of Dermatology, University Hospital Tübingen, Tübingen, Germany

  ⨯
• Ralf Gutzmer,

  Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany

  ⨯
• Stephan Grabbe,

  Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany

  ⨯
• Axel Hauschild,

  Affiliation Department of Dermatology, University Hospital Kiel, Kiel, Germany

  ⨯
• Rüdiger Hein,

  Affiliation Department of Dermatology/III. Medical Department, Technische Universität München, München, Germany

  ⨯
• Gheorghe Hundorfean,

  Affiliation Department of Internal Medicine (Gastroenterology, Endocrinology, and Pneumology), University Hospital Erlangen, Erlangen, Germany

  ⨯
• Armin Justich,

  Affiliation Department of Dermatology, University Hospital Graz, Graz, Austria

  ⨯
• Ullrich Keller,

  Affiliation Department of Dermatology/III. Medical Department, Technische Universität München, München, Germany

  ⨯
• Christina Klein,

  Affiliation Department of Dermatology, University Hospital Mainz, Mainz, Germany

  ⨯
• Christine Mateus,

  Affiliation Institute Gustave Roussy, Department of Dermatology, Villejuif, France

  ⨯
• Peter Mohr ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany

  ⨯
• Sylvie Paetzold ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Frankfurt, Frankfurt, Germany

  ⨯
• Imke Satzger,

  Affiliation Department of Dermatology and Allergy/Department of Pathology, Skin Cancer Center Hannover/Hannover Medical School, Hannover, Germany

  ⨯
• Dirk Schadendorf,

  Affiliation Department of Dermatology, University Hospital Essen, Essen, Germany

  ⨯
• Marc Schlaeppi,

  Affiliation Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

  ⨯
• Gerold Schuler,

  Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany

  ⨯
• Beatrice Schuler-Thurner,

  Affiliation Department of Dermatology, University Hospital Erlangen, Erlangen, Germany

  ⨯
• Uwe Trefzer,

  Affiliation Department of Dermatology, University Hospital Charité Berlin, Berlin, Germany

  ⨯
• Jens Ulrich ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, Hospital Quedlinburg, Quedlinburg, Germany

  ⨯
• Julia Vaubel,

  Affiliation Department of Dermatology, University Hospital Essen, Essen, Germany

  ⨯
• Roger von Moos,

  Affiliation Department of Dermatology, Cantonal Hospital Graubünden, Chur, Switzerland

  ⨯
• Patrik Weder,

  Affiliation Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

  ⨯
• Tabea Wilhelm ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Charité Berlin, Berlin, Germany

  ⨯
• Daniela Göppner ,

  ¶For the ipilimumab network.

  Affiliation Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany

  ⨯
• Reinhard Dummer,

  Affiliation Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
•  [ ... ],
• Lucie M. Heinzerling

  * E-mail: lheinzer@post.harvard.edu

  ¶For the ipilimumab network.

  Affiliations Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, Department of Oncology/Hematology and Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

  ⨯
• [ view all ]
• [ view less ]